Related Experiment Videos
[Transluminal coronary dilatation]
Fortschritte Der Medizin
|December 1, 1983
Insights
Percutaneous transluminal coronary angioplasty (PTCA) is the preferred treatment for single-vessel disease. This procedure can be safely performed outside a hospital setting with appropriate precautions.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Context:
- Single-vessel coronary artery disease management.
- Evaluating treatment options beyond traditional hospital settings.
Purpose:
- To establish percutaneous transluminal coronary angioplasty (PTCA) as a primary treatment for single-vessel disease.
- To assess the feasibility and safety of performing PTCA outside of a hospital with cardiac surgical facilities.
Summary:
- Percutaneous transluminal coronary angioplasty (PTCA) is identified as the optimal treatment strategy for patients diagnosed with single-vessel coronary artery disease.
- The study suggests that PTCA can be conducted with acceptable risk levels in facilities lacking on-site cardiac surgical operating rooms, provided that adequate safety measures are implemented.
Impact:
- Potential to expand access to essential cardiac interventions.
- Highlights the safety and efficacy of outpatient or non-cardiac surgical suite PTCA procedures.
- May influence clinical guidelines and healthcare infrastructure for coronary artery disease treatment.
Abstract:
Percutaneous transluminal coronary angioplasty (PTCA) represents in patients with single-vessel disease the treatment of choice. Under adequate precautions the method can be performed with reasonable risk outside of a hospital with cardiac surgical operating rooms.